Home > Boards > US Listed > Medical - Healthcare > Orasure Technologies (OSUR)

Article today, big things ahead for Orasure. 2021,

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
HokieHead Member Profile
Member Level 
Followed By 817
Posts 52,865
Boards Moderated 6
Alias Born 09/30/04
160x600 placeholder
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/25/2021 4:52:04 PM
Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board GlobeNewswire Inc. - 1/25/2021 6:00:00 AM
OraSure’s Oragene®•Dx Saliva Collection Kit Included in Industry’s First FDA Authorization for a Whole Exome Sequencin... GlobeNewswire Inc. - 1/21/2021 6:00:00 AM
OraSure Technologies Announces 2021 Annual Meeting Date GlobeNewswire Inc. - 1/8/2021 6:00:00 AM
OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 1/5/2021 6:00:00 AM
OraSure’s OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test GlobeNewswire Inc. - 12/23/2020 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/21/2020 4:46:28 PM
OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 ... GlobeNewswire Inc. - 12/21/2020 4:01:00 PM
OraSure Technologies to Present at the 2020 Evercore ISI HealthCONx Conference GlobeNewswire Inc. - 11/30/2020 7:00:00 AM
OraSure Technologies to Commemorate World AIDS Day by Ringing NASDAQ Closing Bell GlobeNewswire Inc. - 11/30/2020 7:00:00 AM
OraSure Technologies to Present at the Stephens Annual Investment Conference 2020 GlobeNewswire Inc. - 11/12/2020 7:00:00 AM
Clinical Reference Laboratory to Market Most Cost-Effective, Gold-Standard Self-Collected COVID-19 Saliva Test Directly to Co... PR Newswire (US) - 11/9/2020 8:02:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:58:40 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 4:21:49 PM
OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments GlobeNewswire Inc. - 11/4/2020 4:01:00 PM
OraSure’s DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect®·RNA Saliva Collection Devic... GlobeNewswire Inc. - 11/3/2020 7:00:00 AM
OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call  Wednesday, November 4, 2020, 5:00 p.m. ET GlobeNewswire Inc. - 10/21/2020 6:00:10 AM
OraSure’s OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2 GlobeNewswire Inc. - 10/19/2020 6:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/28/2020 4:59:05 PM
OraSure’s ORAcollect®·RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 Test GlobeNewswire Inc. - 9/24/2020 6:00:10 AM
Former CEO of H2O+ Beauty, Former Chief Chemist of MAC Cosmetics Launch Innovative Skincare Brand Using First-Ever Scientific... GlobeNewswire Inc. - 9/15/2020 12:00:10 PM
Correction to Rapid Covid-19 Tests Article (Sept. 8) Dow Jones News - 9/9/2020 1:02:00 PM
OraSure’s ORAcollect®·RNA Device Included in EUA Granted to MiraDx Inc. for SARS-CoV-2 Test GlobeNewswire Inc. - 9/3/2020 4:30:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/1/2020 6:00:36 AM
OraSure Technologies to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 8/27/2020 4:30:10 PM
HokieHead Member Level  Friday, 05/08/20 09:45:41 PM
Re: None
Post # of 368 
Article today, big things ahead for Orasure. 2021, possibly billions of units, that’s huge revenues..

Quote:
OraSure President and CEO Stephen Tang said the company began considering developing a test as COVID-19 began spreading in January and February.

The company plans to develop a SARS-CoV-2 that, like its HIV test, will be suitable for home use and can provide results in under an hour, Tang said. He said the company aims to launch the product in September. Tang said that OraSure can currently manufacture about 13 million tests per year.

He noted, however, that some official plans to safely reopen the economy call for a billion tests per year.

"We're going to have to find a way to massively scale up," he said. "We're looking to design massive manufacturing of this from the start. Our job is to find facilities and manufacturers and partners who can jump in quickly to that manufacturing environment."

He said he anticipated being able to reach "full-scale manufacturing sometime in 2021," with a target of "tens of millions to a billion units per year."



https://www.modernhealthcare.com/technology/rapid-antigen-assays-could-prove-key-addressing-sars-cov-2-testing-limitations

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences